James Raftery

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. ncbi Possible net harms of breast cancer screening: updated modelling of Forrest report
    James Raftery
    Faculty of Medicine, Wessex Institute, University of Southampton, Southampton SO16 7PX, UK
    BMJ 343:d7627. 2011
  2. ncbi Review of NICE's recommendations, 1999-2005
    James Raftery
    Wessex Institute of Health Research and Development, University of Southampton, Southampton SO16 7PX
    BMJ 332:1266-8. 2006
  3. ncbi A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers
    Ruth Davies
    School of Management, University of Southampton, UK
    Health Care Manag Sci 5:249-58. 2002
  4. ncbi "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation
    Louise Dent
    University of Southampton Clinical Trials Unit MP131, University of Southampton, SO16 6YD, UK
    Trials 12:83. 2011
  5. ncbi The CHD challenge: comparing four cost-effectiveness models
    David Turner
    Wessex Institute University of Southampton, Southampton, UK
    Value Health 14:53-60. 2011
  6. ncbi Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach
    James Raftery
    School of Medicine, University of Southampton, Southhampton, UK
    Int J Technol Assess Health Care 25:1-5. 2009
  7. ncbi An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone support
    Lucy Yardley
    School of Psychology, University of Southampton, Highfield, Southampton, UK
    BMC Ear Nose Throat Disord 9:13. 2009
  8. ncbi Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists
    James Raftery
    Wessex Institute for Health R and D, School of Medicine, University of Southampton, Southampton, UK
    Trials 10:15. 2009
  9. ncbi Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial
    David Turner
    Wessex Institute, University of Southampton, Alpha House, Southampton Science Park, Chilworth, Southampton SO16 7NS
    BMJ 340:c346. 2010
  10. ncbi Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
    James Raftery
    Wessex Institute for Health R and D, Medical School, University of Southampton, Southampton, UK
    Br J Ophthalmol 91:1244-6. 2007

Collaborators

Detail Information

Publications22

  1. ncbi Possible net harms of breast cancer screening: updated modelling of Forrest report
    James Raftery
    Faculty of Medicine, Wessex Institute, University of Southampton, Southampton SO16 7PX, UK
    BMJ 343:d7627. 2011
    ..To assess the claim in a Cochrane review that mammographic breast cancer screening could be doing more harm than good by updating the analysis in the Forrest report, which led to screening in the United Kingdom...
  2. ncbi Review of NICE's recommendations, 1999-2005
    James Raftery
    Wessex Institute of Health Research and Development, University of Southampton, Southampton SO16 7PX
    BMJ 332:1266-8. 2006
  3. ncbi A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers
    Ruth Davies
    School of Management, University of Southampton, UK
    Health Care Manag Sci 5:249-58. 2002
    ..A factorial design analysis showed the sensitivity of key variables. An increase in the opportunistic testing was found significantly to reduce the impact of screening...
  4. ncbi "Flogging dead horses": evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation
    Louise Dent
    University of Southampton Clinical Trials Unit MP131, University of Southampton, SO16 6YD, UK
    Trials 12:83. 2011
    ..Measures of sufficiency and stability may indicate whether this is true.Objectives: To show how evidence accumulated on centre-based versus home-based cardiac rehabilitation, including estimates of sufficiency and stability..
  5. ncbi The CHD challenge: comparing four cost-effectiveness models
    David Turner
    Wessex Institute University of Southampton, Southampton, UK
    Value Health 14:53-60. 2011
    ....
  6. ncbi Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approach
    James Raftery
    School of Medicine, University of Southampton, Southhampton, UK
    Int J Technol Assess Health Care 25:1-5. 2009
    ..This study assesses the impact of the English National Health Service (NHS) Health Technology Assessment (HTA) program using the "payback" framework...
  7. ncbi An evaluation of the cost-effectiveness of booklet-based self-management of dizziness in primary care, with and without expert telephone support
    Lucy Yardley
    School of Psychology, University of Southampton, Highfield, Southampton, UK
    BMC Ear Nose Throat Disord 9:13. 2009
    ..The aim of this trial is to evaluate two new alternative models of delivery that may be more feasible and cost-effective...
  8. ncbi Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists
    James Raftery
    Wessex Institute for Health R and D, School of Medicine, University of Southampton, Southampton, UK
    Trials 10:15. 2009
    ..The aims were to review relevant guidelines and to collate and analyse views of clinical trialists on the role of payments and other factors that motivated clinicians to join clinical trials...
  9. ncbi Cost effectiveness of management strategies for urinary tract infections: results from randomised controlled trial
    David Turner
    Wessex Institute, University of Southampton, Alpha House, Southampton Science Park, Chilworth, Southampton SO16 7NS
    BMJ 340:c346. 2010
    ..To assess the cost effectiveness of different management strategies for urinary tract infections...
  10. ncbi Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
    James Raftery
    Wessex Institute for Health R and D, Medical School, University of Southampton, Southampton, UK
    Br J Ophthalmol 91:1244-6. 2007
    ..Continued unlicensed use of bevacizumab raises ethical, legal and policy questions. Public pressure may be the most potent weapon in persuading Genentech to license bevacizumab for AMD...
  11. ncbi Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis
    Fujian Song
    Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK
    Med Decis Making 22:S26-37. 2002
    ..The cost-effectiveness of adding NRT and bupropion SR to advice or counseling for smoking cessation is better than many other accepted health care interventions...
  12. ncbi 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation
    Miren Jones
    Department of Primary Care and General Practice, University of Birmingham, Birmingham, UK
    Fam Pract 24:343-57. 2007
    ..Cardiac rehabilitation (CR) has been shown to improve prognosis and function following an acute myocardial infarction or revascularization. However, participation in CR programmes is low and adherence is poor...
  13. ncbi Assessing the economic challenges posed by orphan drugs: a comment on Drummond et al
    Christopher McCabe
    Int J Technol Assess Health Care 23:397-401; author reply 401-4. 2007
  14. ncbi Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis
    Sue Jowett
    Health Economics Facility, Health Services Management Centre, University of Birmingham, Birmingham, UK
    Br J Haematol 134:632-9. 2006
    ..However, PSM may have other benefits in relieving pressure on traditional clinic-based care, and the cost-effectiveness of this model of care for some subgroups of anticoagulation patients needs to be explored further...
  15. ncbi Predicting the impact of new health technologies on average length of stay: development of a prediction framework
    Sue Simpson
    Dept of Public Health and Epidemiology, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    Int J Technol Assess Health Care 21:487-91. 2005
    ..The aim of this study was to develop a framework to predict the impact of new health technologies on average length of hospital stay...
  16. ncbi Can health technologies be assessed using routine data?
    Andrew J Stevens
    Department of Public Health and Epidemiology, University of Birmingham, UK
    Int J Technol Assess Health Care 21:96-103. 2005
    ..The potential of routine data for health technology assessment (HTA) in the United Kingdom was assessed...
  17. ncbi Comparing processes of stroke care in high- and low-mortality hospitals in the West Midlands, UK
    Mohammed A Mohammed
    Public Health and Epidemiology, Birmingham University, Birmingham, UK
    Int J Qual Health Care 17:31-6. 2005
    ....
  18. ncbi Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: trend analysis and comparison with need
    Claire Packer
    Department of Public Health and Epidemiology, The University of Birmingham, Edgbaston, UK
    Int J Technol Assess Health Care 20:531-6. 2004
    ..To describe the adoption and take up of thrombolytic agents for acute myocardial infarction since 1980 in England and compare use with the estimated ceiling of need...
  19. ncbi A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]
    Dawn Swancutt
    Department of Primary Care and General Practice, The University of Birmingham, UK
    BMC Cardiovasc Disord 4:12. 2004
    ..AF detection rates in systematically screened and opportunistically screened populations in the intervention practices were compared to AF detection rate in 5,000 patients in the control practices...
  20. ncbi Counting in-hospital deaths in England: a comparison of hospital computer systems and mortuary registers
    Mohammed Mohammed
    Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK
    J Health Serv Res Policy 9:100-3. 2004
    ..DISCUSSION: The differences between the two sources of in-hospital death counts were not large enough to influence the Dr Foster ranks but were sufficient to raise concern about the validity and completeness of mortality data in the NHS...
  21. ncbi Ethnic and sex bias in discretionary awards
    James Raftery
    BMJ 326:671-2. 2003
  22. ncbi NHS activity. Running out of juice
    James Raftery
    Health Services Management Centre, Birmingham University
    Health Serv J 112:22-3. 2002
    ..Current measurement indicators do not take account of quality, so improvement to services may show up as decreases in efficiency. Quality improvements should be included in productivity measurement...